OpenLink Launches the First Comprehensive Trading, Treasury and Risk Cloud Platform
16.5.2017 07:01:00 EEST | Business Wire | Press release
OpenLink, the global leader in trading, treasury and risk management solutions for the energy, commodities, corporate and financial services industries, today announced the launch of OpenLink Cloud – the world’s first and most comprehensive enterprise Cloud platform for trading, treasury and risk management.
OpenLink Cloud is designed to transform trading, treasury and risk departments, combining the best of OpenLink’s flagship products with an extensible and transparent platform for unprecedented agility and innovation. Delivering the highest standards of security for highly regulated, data-intensive organizations, OpenLink Cloud combines the strength and security of the Microsoft Azure platform with best-of-breed OpenLink security and tools to ensure that our clients’ mission-critical systems and data are protected at all times.
Patrick Reames, Managing Partner of Commodity Technology Advisory the leading CTRM market analyst firm noted: “While Cloud deployment of commodity trading solutions in the low and mid-tiers of the market has increased in recent years, the investment by OpenLink in the OpenLink Cloud will undoubtedly accelerate this movement across all tiers of the market. The commitment by many of the world’s largest energy and commodity trading firms to adopt OpenLink’s enterprise-scale Cloud solutions is a pivotal development in terms of how these systems will be deployed going forward.”
Jack Large, Cash and Treasury Management Consultant and Analyst for CTMfile, said, “The wait is over. There is now enough power and security in the OpenLink Cloud to move mission critical systems to their Cloud platform, combined with OpenLink’s functional strength in cash and treasury management, extensive trading, commodities and risk management, could make this combination a game changer. Time will tell.”
Developed in collaboration with over 50 of OpenLink’s largest and most sophisticated energy and financial services clients, OpenLink Cloud has been rigorously tested by those who place the highest demands on the software. Supported by a robust set of custom tools and services, OpenLink Cloud is designed to help clients of all sizes get up and running quickly and to simplify management, monitoring and support of both production and non-production environments. Customers will have immediate access to almost limitless computing power with the introduction of OpenLink’s dynamic scaling capabilities, providing advanced data management and richer analytics that enable greater market understanding, speed and evidence-based decision-making.
John O’Malley, CEO of OpenLink, added: “If you think you knew OpenLink, take another look. We have made a significant investment in OpenLink Cloud in response to our clients’ feedback. They are looking to reduce costs, advance risk analytics and scale their operations to transform how they run their businesses. The response from clients and pent-up demand from prospects has been staggering. OpenLink Cloud enables us to deliver our market leading solutions faster and with attractive subscription pricing models.”
Scott Rompala, Head of the Cloud Solutions Group at OpenLink, said: “The real untapped benefit our clients are sharing is how this new flexibility and efficiency will allow them to reimagine their business, take advantage of intraday volatility in the markets, and provide accurate and real-time views of their risk and exposures to management and the board on demand.”
OpenLink Cloud facilitates calculations of P&L and VaR-type metrics more frequently and with broader data sets. These enhanced capabilities will enable departments to produce real-time analytics and improved hedging strategies, optimize capital movement and provide greater insight into profitability drivers, enhancing overall the information available for decision-making.
The OpenLink Cloud platform integrates an ecosystem of multiple tools and partners to provide a complete solution with comprehensive security, supported 24x7 by OpenLink Cloud experts. With new subscription-based pricing and dynamic scaling our clients can now better manage cost, risk and implement a platform for unrivalled innovation.
For further information please visit openlink.cloud
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170515005240/en/
Contact information
Aspectus for OpenLink
Ellie Bacon (UK) / Bar Cudkevich (US)
+44
20 7242 8867 / +1 646 202 9845
openlink@aspectuspr.com
or
OpenLink
Michael
Golding, +44 7766398912
Global Head of Public Relations
michael.golding@openlink.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 15:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.
Fortegra Completes Acquisition by DB Insurance29.5.2026 23:30:00 EEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom